- Home
- Immunology
- Long-Term Efficacy Outcomes of Targeted Kinase Inhibition in Systemic Lupus Erythematosus
1mo3 min read
Medical Article
Introduction: Systemic lupus erythematosus(SLE) is a chronic, multisystem autoimmune disorder that disproportionately affects women (~90% of patients) and presents significant management challenges due to its heterogeneity and resistance to conventional therapies (1). Despite new agents, sustained remission remains difficult for many patients. Upad

Long-Term Efficacy Outcomes of Targeted Kinase Inhibition in Systemic Lupus Erythematosus
191 Reached2 Comments
Similar Content

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Post-partum Septic Arthritis of the Knee
424 Reached2 Comments1 Likes

Woman with Persistent Lyme Disease
57 Reached

Unilateral Sacroiliitis following Dengue Virus Infection in Young Girl
280 Reached2 Comments3 Likes

Male with Complaint of Neck Pain and Sore Throat
400 Reached12 Comments9 Likes
